Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
NCNA

Overview Financials Analysis Smart Money

NuCana plc

NCNA · NASDAQ

Analyze with AI

Filings1

Total reported value$11.4M

Manager	Shares	Value	Change
Abingworth LLP	3.3M	$11.4M	0.0%

SymbolNCNA

Market Cap$20.8M

IPO Date2017-09-28

CEOHugh Stephen Griffith

Employees20

SectorHealthcare

IndustryBiotechnology

CountryGB

ExchangeNASDAQ Global Select

Mega Fortune Company Limited

MGRT

$13.05

+143.93%

Processa Pharmaceuticals, Inc.

PCSA

$6.68

+122.30%

cbdMD, Inc.

YCBD

$2.27

+58.74%

Agape ATP Corporation

ATPC

$0.1408

+56.44%

VYNE Therapeutics Inc.

VYNE

$0.60

+48.99%

Peers

MetaVia Inc.

MTVA · NASDAQ

$8.23

+1.11%

Lisata Therapeutics, Inc.

LSTA · NASDAQ

$2.01

-1.95%

Passage Bio, Inc.

PASG · NASDAQ

$9.01

-4.66%

Enlivex Therapeutics Ltd.

ENLV · NASDAQ

$0.8339

-1.43%

CytoMed Therapeutics Limited

GDTC · NASDAQ

$1.58

-1.86%

CASI Pharmaceuticals, Inc.

CASI · NASDAQ

$0.8421

-4.31%

Pelthos Therapeutics Inc.

PTHS · NYSE

$22.35

+2.38%

CollPlant Biotechnologies Ltd.

CLGN · NASDAQ

$1.41

-7.84%

NeuroSense Therapeutics Ltd.

NRSN · NASDAQ

$0.83

-2.35%

Clearside Biomedical, Inc.

CLSD · NASDAQ

$1.00

-3.85%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.